One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The renal heading covers adults and children aged at least 3 months weighing more than 40 kg; it is not a small-child or neonatal schedule. The source also specifies additional doses both during and at the end of hemodialysis.
What to reconcile: Confirm population and local dialysis protocol. Do not silently change the source schedule.
Open this note and its source referencesGalway uses indexed eGFR and inpatient IV/PO ranges, whereas UCSF provides indication-specific oral CrCl schedules and specified dialysis assumptions. The printed UCSF headings leave exactly 30 unassigned. These protocols are not interchangeable.
What to reconcile: Resolve the printed boundary and match the indication, oral route and actual dialysis prescription.
Open this note and its source referencesKeep route, indication, renal measure and dialysis modality together; do not merge the Galway and UCSF regimens.
The asterisk marks significant differences among references. Usual dosing means the local normal-renal/hepatic regimen.
CRRT is outside this guideline. Route, severity and renal measure must remain attached; do not combine its interval with another source dose.
| Indexed eGFR (mL/min/1.73 m2) | Source-specific instruction |
|---|---|
| 10-50 | No renal dose adjustment in this institutional table |
| <10 | 250 mg to 1 g every 8 hours |
| <10, high-dose endocarditis or Listeria meningitis | Maximum 2 g every 8 hours |
Galway amoxicillin IV/PO - hospitalized adults
| Indexed eGFR (mL/min/1.73 m2) | Source-specific instruction |
|---|---|
| 10-50 | No renal dose adjustment in this institutional table |
| <10 | 250 mg to 1 g every 8 hours |
| <10, high-dose endocarditis or Listeria meningitis | Maximum 2 g every 8 hours |
The asterisk marks significant differences among references. Usual dosing means the local normal-renal/hepatic regimen.
CRRT is outside this guideline. Route, severity and renal measure must remain attached; do not combine its interval with another source dose.
RDM64-professional-amoxicillin-74ab8780ac-C1 · Source locator: General Principles; Assessing Renal Function; amoxicillin row; Renal Replacement Therapy.
The asterisk marks significant differences among references. Usual dosing means the local normal-renal/hepatic regimen.
CRRT is outside this guideline. Route, severity and renal measure must remain attached; do not combine its interval with another source dose.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=amoxicillin&s1=RDM64-professional-amoxicillin-74ab8780ac&h1=a1748698a1dcfbe3ffc2b3dcb98aa17490a2771365e714c516045c07a4e6d12d